DLHL
ATRS

Donald L. Hagan LLC’s Antares Pharma, Inc. ATRS Stock Holding History

Donald L. Hagan LLC’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,000
Closed -$2K – 333
2016
Q1 		$2K Buy
+2,000
New +$1.94K ﹤0.01% 357
2015
Q4 		– Sell
-44,000
Closed -$75K – 330
2015
Q3 		$75K Hold
44,000
– – 0.07% 109
2015
Q2 		$92K Hold
44,000
– – 0.09% 70
2015
Q1 		$119K Hold
44,000
– – 0.12% 75
2014
Q4 		$113K Buy
+44,000
New +$98.8K 0.11% 79

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLP
Pleasant Lake Partners Rincon, Puerto Rico $7.91M AUM 5.74% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Donald L. Hagan LLC's ATRS Position: Q2 2016 in Review

Donald L. Hagan LLC sold out of Antares Pharma, Inc. (ATRS) in Q2 2016, closing a stake of 2,000 shares — an estimated $2K sold.

Donald L. Hagan LLC first reported a position in ATRS in Q4 2014 and held it in 5 quarters. The position peaked at $119K in Q1 2015. 71 funds tracked by Wall St. Rank hold ATRS as of Q2 2016.

  • Donald L. Hagan LLC reported no remaining Antares Pharma, Inc. position as of Q2 2016 after selling out during the quarter.
  • Donald L. Hagan LLC sold 2,000 Antares Pharma, Inc. shares in Q2 2016, an estimated $2K.
  • Donald L. Hagan LLC first reported a position in Antares Pharma, Inc. in Q4 2014 and held it in 5 quarters.
  • Donald L. Hagan LLC's Antares Pharma, Inc. position peaked at $119K in Q1 2015.
  • 71 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2016.

Based on Donald L. Hagan LLC's 13F filing for Q2 2016, filed 21 Jul 2016.